435 related articles for article (PubMed ID: 22496332)
21. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
von der Lippe B; Sandven P; Brubakk O
J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
24. WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.
Chang KC; Yew WW; Tam CM; Leung CC
Antimicrob Agents Chemother; 2013 Sep; 57(9):4097-104. PubMed ID: 23774431
[TBL] [Abstract][Full Text] [Related]
25. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
Condos R; Hadgiangelis N; Leibert E; Jacquette G; Harkin T; Rom WN
Chest; 2008 Jul; 134(1):187-92. PubMed ID: 18628223
[TBL] [Abstract][Full Text] [Related]
26. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB;
Eur Respir J; 2013 Jul; 42(1):288-90. PubMed ID: 23813314
[No Abstract] [Full Text] [Related]
27. Retrospective study of tolerability and efficacy of linezolid in patients with multidrug-resistant tuberculosis (1998-2014).
Ramírez-Lapausa M; Pascual Pareja JF; Carrillo Gómez R; Martínez-Prieto M; González-Ruano Pérez P; Noguerado Asensio A
Enferm Infecc Microbiol Clin; 2016 Feb; 34(2):85-90. PubMed ID: 26015067
[TBL] [Abstract][Full Text] [Related]
28. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
29. Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China.
Zhang P; Tan J; Lin Y; Zhang H; Deng G; Chen X
Drug Discov Ther; 2022 May; 16(2):96-98. PubMed ID: 35444071
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
Tangg SJ; Zhang Q; Zheng LH; Sun H; Gu J; Hao XH; Liu YD; Yao L; Xiao HP
Jpn J Infect Dis; 2011; 64(6):509-12. PubMed ID: 22116331
[TBL] [Abstract][Full Text] [Related]
31. The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Hasan T; Medcalf E; Nyang'wa BT; Egizi E; Berry C; Dodd M; Foraida S; Gegia M; Li M; Mirzayev F; Morgan H; Motta I; Nguyen L; Schumacher S; Schlub T; Fox G
Clin Infect Dis; 2024 Mar; 78(3):730-741. PubMed ID: 37874021
[TBL] [Abstract][Full Text] [Related]
32. Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
Lifan Z; Sainan B; Feng S; Siyan Z; Xiaoqing L
Int J Tuberc Lung Dis; 2019 Dec; 23(12):1293-1307. PubMed ID: 31931914
[No Abstract] [Full Text] [Related]
33. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
Abbate E; Vescovo M; Natiello M; Cufré M; García A; Gonzalez Montaner P; Ambroggi M; Ritacco V; van Soolingen D
J Antimicrob Chemother; 2012 Feb; 67(2):473-7. PubMed ID: 22134348
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.
Zhang X; Falagas ME; Vardakas KZ; Wang R; Qin R; Wang J; Liu Y
J Thorac Dis; 2015 Apr; 7(4):603-15. PubMed ID: 25973226
[TBL] [Abstract][Full Text] [Related]
35. Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
Yang M; Zhan S; Fu L; Wang Y; Zhang P; Deng G
Drug Discov Ther; 2022 May; 16(2):99-101. PubMed ID: 35418550
[TBL] [Abstract][Full Text] [Related]
36. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Pym AS; Diacon AH; Tang SJ; Conradie F; Danilovits M; Chuchottaworn C; Vasilyeva I; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; Van Baelen B; van Heeswijk RP; Dannemann B;
Eur Respir J; 2016 Feb; 47(2):564-74. PubMed ID: 26647431
[TBL] [Abstract][Full Text] [Related]
37. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
Muñoz-Torrico M; Caminero Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Ergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
Rev Port Pneumol (2006); 2017; 23(1):27-30. PubMed ID: 28043788
[TBL] [Abstract][Full Text] [Related]
38. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
[TBL] [Abstract][Full Text] [Related]
39. Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?
Manfredi R; Nanetti A; Dal Monte P; Calza L
Braz J Infect Dis; 2009 Aug; 13(4):297-303. PubMed ID: 20231995
[TBL] [Abstract][Full Text] [Related]
40. Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
Sotgiu G; Centis R; D'Ambrosio L; Castiglia P; Migliori GB
Eur Respir J; 2015 Jan; 45(1):287-9. PubMed ID: 25552740
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]